FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155186970> ?p ?o ?g. }

• W2155186970 endingPage "899" @default.
• W2155186970 startingPage "893" @default.
• W2155186970 abstract "Background COPD is a chronic inflammatory disorder with high risk of cardiovascular morbidity and mortality. Adiponectin is a hormone that has antiinflammatory, antidiabetic, and antiatherogenic activities. We investigated the relationship of serum adiponectin to health outcomes in COPD. Methods We measured adiponectin levels in serum samples from participants of the Lung Health Study, who were smokers with mild to moderate airflow limitation. We determined the relationship of serum adiponectin to hospitalization and mortality using a Cox proportional hazards model and to baseline lung function measurements and bronchial reactivity using multiple regression methods. Results Serum adiponectin concentrations were inversely related to hospitalizations and mortality from coronary heart disease (hazard ratio [HR], 0.73; 95% CI, 0.62-0.86) and to cardiovascular disease (HR, 0.83; 95% CI, 0.73-0.94) and positively related to deaths from respiratory causes (HR, 2.09; 95% CI, 1.41-3.11). However, serum adiponectin concentrations were not significantly related to total mortality (HR, 1.10; 95% CI, 0.93-1.29) or cancer-related mortality (HR, 1.11; 95% CI, 0.92-1.34). Serum adiponectin concentrations were significantly related to increased bronchial reactivity and an accelerated decline in lung function (both P < .0001). Smoking status had no material influence on serum adiponectin concentrations. Conclusions Adiponectin is a complex serum biomarker in COPD that is associated with decreased risk of cardiovascular events but increased risk of respiratory mortality. Because serum adiponectin is not significantly influenced by smoking status, it is a very promising biomarker of cardiovascular outcomes in COPD. COPD is a chronic inflammatory disorder with high risk of cardiovascular morbidity and mortality. Adiponectin is a hormone that has antiinflammatory, antidiabetic, and antiatherogenic activities. We investigated the relationship of serum adiponectin to health outcomes in COPD. We measured adiponectin levels in serum samples from participants of the Lung Health Study, who were smokers with mild to moderate airflow limitation. We determined the relationship of serum adiponectin to hospitalization and mortality using a Cox proportional hazards model and to baseline lung function measurements and bronchial reactivity using multiple regression methods. Serum adiponectin concentrations were inversely related to hospitalizations and mortality from coronary heart disease (hazard ratio [HR], 0.73; 95% CI, 0.62-0.86) and to cardiovascular disease (HR, 0.83; 95% CI, 0.73-0.94) and positively related to deaths from respiratory causes (HR, 2.09; 95% CI, 1.41-3.11). However, serum adiponectin concentrations were not significantly related to total mortality (HR, 1.10; 95% CI, 0.93-1.29) or cancer-related mortality (HR, 1.11; 95% CI, 0.92-1.34). Serum adiponectin concentrations were significantly related to increased bronchial reactivity and an accelerated decline in lung function (both P < .0001). Smoking status had no material influence on serum adiponectin concentrations. Adiponectin is a complex serum biomarker in COPD that is associated with decreased risk of cardiovascular events but increased risk of respiratory mortality. Because serum adiponectin is not significantly influenced by smoking status, it is a very promising biomarker of cardiovascular outcomes in COPD." @default.
• W2155186970 created "2016-06-24" @default.
• W2155186970 creator A5009947587 @default.
• W2155186970 creator A5018378418 @default.
• W2155186970 creator A5019236240 @default.
• W2155186970 creator A5021661618 @default.
• W2155186970 creator A5022269910 @default.
• W2155186970 creator A5027761713 @default.
• W2155186970 creator A5042188739 @default.
• W2155186970 creator A5042635009 @default.
• W2155186970 creator A5062711392 @default.
• W2155186970 creator A5089798726 @default.
• W2155186970 date "2012-10-01" @default.
• W2155186970 modified "2023-09-27" @default.
• W2155186970 title "The Complex Relationship of Serum Adiponectin to COPD Outcomes" @default.
• W2155186970 cites W1609604630 @default.
• W2155186970 cites W1858372111 @default.
• W2155186970 cites W1978590803 @default.
• W2155186970 cites W1997978122 @default.
• W2155186970 cites W2003522557 @default.
• W2155186970 cites W2003915865 @default.
• W2155186970 cites W2007286329 @default.
• W2155186970 cites W2017149727 @default.
• W2155186970 cites W2019294851 @default.
• W2155186970 cites W2019823288 @default.
• W2155186970 cites W2034745853 @default.
• W2155186970 cites W2069497802 @default.
• W2155186970 cites W2081222896 @default.
• W2155186970 cites W2081393100 @default.
• W2155186970 cites W2099692602 @default.
• W2155186970 cites W2106293827 @default.
• W2155186970 cites W2107345178 @default.
• W2155186970 cites W2116141140 @default.
• W2155186970 cites W2120794490 @default.
• W2155186970 cites W2122484262 @default.
• W2155186970 cites W2125361392 @default.
• W2155186970 cites W2134100055 @default.
• W2155186970 cites W2156248782 @default.
• W2155186970 cites W2156489014 @default.
• W2155186970 cites W2159549674 @default.
• W2155186970 cites W2168131128 @default.
• W2155186970 doi "https://doi.org/10.1378/chest.11-2173" @default.
• W2155186970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22207678" @default.
• W2155186970 hasPublicationYear "2012" @default.
• W2155186970 type Work @default.
• W2155186970 sameAs 2155186970 @default.
• W2155186970 citedByCount "47" @default.
• W2155186970 countsByYear W21551869702012 @default.
• W2155186970 countsByYear W21551869702013 @default.
• W2155186970 countsByYear W21551869702014 @default.
• W2155186970 countsByYear W21551869702015 @default.
• W2155186970 countsByYear W21551869702016 @default.
• W2155186970 countsByYear W21551869702017 @default.
• W2155186970 countsByYear W21551869702018 @default.
• W2155186970 countsByYear W21551869702019 @default.
• W2155186970 countsByYear W21551869702020 @default.
• W2155186970 countsByYear W21551869702021 @default.
• W2155186970 countsByYear W21551869702022 @default.
• W2155186970 countsByYear W21551869702023 @default.
• W2155186970 crossrefType "journal-article" @default.
• W2155186970 hasAuthorship W2155186970A5009947587 @default.
• W2155186970 hasAuthorship W2155186970A5018378418 @default.
• W2155186970 hasAuthorship W2155186970A5019236240 @default.
• W2155186970 hasAuthorship W2155186970A5021661618 @default.
• W2155186970 hasAuthorship W2155186970A5022269910 @default.
• W2155186970 hasAuthorship W2155186970A5027761713 @default.
• W2155186970 hasAuthorship W2155186970A5042188739 @default.
• W2155186970 hasAuthorship W2155186970A5042635009 @default.
• W2155186970 hasAuthorship W2155186970A5062711392 @default.
• W2155186970 hasAuthorship W2155186970A5089798726 @default.
• W2155186970 hasConcept C126322002 @default.
• W2155186970 hasConcept C134018914 @default.
• W2155186970 hasConcept C185592680 @default.
• W2155186970 hasConcept C207103383 @default.
• W2155186970 hasConcept C2776780178 @default.
• W2155186970 hasConcept C2776782570 @default.
• W2155186970 hasConcept C2777391703 @default.
• W2155186970 hasConcept C2781197716 @default.
• W2155186970 hasConcept C44249647 @default.
• W2155186970 hasConcept C50382708 @default.
• W2155186970 hasConcept C511355011 @default.
• W2155186970 hasConcept C55493867 @default.
• W2155186970 hasConcept C71924100 @default.
• W2155186970 hasConcept C90924648 @default.
• W2155186970 hasConceptScore W2155186970C126322002 @default.
• W2155186970 hasConceptScore W2155186970C134018914 @default.
• W2155186970 hasConceptScore W2155186970C185592680 @default.
• W2155186970 hasConceptScore W2155186970C207103383 @default.
• W2155186970 hasConceptScore W2155186970C2776780178 @default.
• W2155186970 hasConceptScore W2155186970C2776782570 @default.
• W2155186970 hasConceptScore W2155186970C2777391703 @default.
• W2155186970 hasConceptScore W2155186970C2781197716 @default.
• W2155186970 hasConceptScore W2155186970C44249647 @default.
• W2155186970 hasConceptScore W2155186970C50382708 @default.
• W2155186970 hasConceptScore W2155186970C511355011 @default.
• W2155186970 hasConceptScore W2155186970C55493867 @default.
• W2155186970 hasConceptScore W2155186970C71924100 @default.
• W2155186970 hasConceptScore W2155186970C90924648 @default.

• next